マイクロバイオームの世界市場 2024-2028

概要

マイクロバイオーム市場は2023-2028年に11億3,278万米ドル、予測期間中のCAGRは22.67%で成長すると予測されます。

当レポートでは、マイクロバイオーム市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、疾患の有病率の増加、マイクロバイオーム研究に対する取り組みや投資の増加、マイクロバイオーム探索・治療・診断の進歩などによって牽引されています。

本調査では、マイクロバイオーム治療薬開発のための多数の共同研究が、今後数年間のマイクロバイオーム市場開拓を促進する主要な理由の1つであると指摘しています。また、バイオセンサや遺伝子回路の開発への注目の高まりや規制枠組みの進展は、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• マイクロバイオームの世界市場 2018-2022
• 製品セグメント分析 2018-2022
• 用途別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• プロバイオティクス：市場規模と予測 2023-2028
• 食品：市場規模と予測 2023-2028
• プレバイオティクス：市場規模と予測 2023-2028
• 医療用食品：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：製品別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 治療学：市場規模と予測 2023-2028
• 診断：市場規模と予測 2023-2028
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AOBiome LLC
• BiomX Inc.
• DuPont de Nemours Inc.
• Eligo Bioscience
• ENTEROME SA
• Evelo Biosciences Inc.
• ExeGi Pharma
• Ferring BV
• OraSure Technologies Inc.
• Osel Inc.
• PureTech Health Plc
• Second Genome Therapeutics
• Seres Therapeutics Inc.
• Synlogic Inc.
• THERIVA BIOLOGICS INC.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global microbiomes market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Product - Market share 2023-2028 (%)
• Exhibits31: Data Table on Product - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Probiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Probiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Probiotics - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Probiotics - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Foods - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Foods - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Foods - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Foods - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Prebiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Prebiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Prebiotics - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Prebiotics - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Medical food - Market size and forecast 2023-2028 ($ million)
• Exhibits47: Data Table on Medical food - Market size and forecast 2023-2028 ($ million)
• Exhibits48: Chart on Medical food - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Medical food - Year-over-year growth 2023-2028 (%)
• Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits54: Market opportunity by Product ($ million)
• Exhibits55: Data Table on Market opportunity by Product ($ million)
• Exhibits56: Chart on Application - Market share 2023-2028 (%)
• Exhibits57: Data Table on Application - Market share 2023-2028 (%)
• Exhibits58: Chart on Comparison by Application
• Exhibits59: Data Table on Comparison by Application
• Exhibits60: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Application ($ million)
• Exhibits69: Data Table on Market opportunity by Application ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: AOBiome LLC - Overview
• Exhibits120: AOBiome LLC - Product / Service
• Exhibits121: AOBiome LLC - Key offerings
• Exhibits122: BiomX Inc. - Overview
• Exhibits123: BiomX Inc. - Product / Service
• Exhibits124: BiomX Inc. - Key offerings
• Exhibits125: DuPont de Nemours Inc. - Overview
• Exhibits126: DuPont de Nemours Inc. - Business segments
• Exhibits127: DuPont de Nemours Inc. - Key news
• Exhibits128: DuPont de Nemours Inc. - Key offerings
• Exhibits129: DuPont de Nemours Inc. - Segment focus
• Exhibits130: Eligo Bioscience - Overview
• Exhibits131: Eligo Bioscience - Product / Service
• Exhibits132: Eligo Bioscience - Key offerings
• Exhibits133: ENTEROME SA - Overview
• Exhibits134: ENTEROME SA - Product / Service
• Exhibits135: ENTEROME SA - Key offerings
• Exhibits136: Evelo Biosciences Inc. - Overview
• Exhibits137: Evelo Biosciences Inc. - Product / Service
• Exhibits138: Evelo Biosciences Inc. - Key offerings
• Exhibits139: ExeGi Pharma - Overview
• Exhibits140: ExeGi Pharma - Product / Service
• Exhibits141: ExeGi Pharma - Key offerings
• Exhibits142: Ferring BV - Overview
• Exhibits143: Ferring BV - Product / Service
• Exhibits144: Ferring BV - Key offerings
• Exhibits145: OraSure Technologies Inc. - Overview
• Exhibits146: OraSure Technologies Inc. - Business segments
• Exhibits147: OraSure Technologies Inc. - Key offerings
• Exhibits148: OraSure Technologies Inc. - Segment focus
• Exhibits149: Osel Inc. - Overview
• Exhibits150: Osel Inc. - Product / Service
• Exhibits151: Osel Inc. - Key offerings
• Exhibits152: PureTech Health Plc - Overview
• Exhibits153: PureTech Health Plc - Business segments
• Exhibits154: PureTech Health Plc - Key offerings
• Exhibits155: PureTech Health Plc - Segment focus
• Exhibits156: Second Genome Therapeutics - Overview
• Exhibits157: Second Genome Therapeutics - Product / Service
• Exhibits158: Second Genome Therapeutics - Key offerings
• Exhibits159: Seres Therapeutics Inc. - Overview
• Exhibits160: Seres Therapeutics Inc. - Product / Service
• Exhibits161: Seres Therapeutics Inc. - Key offerings
• Exhibits162: Synlogic Inc. - Overview
• Exhibits163: Synlogic Inc. - Product / Service
• Exhibits164: Synlogic Inc. - Key offerings
• Exhibits165: THERIVA BIOLOGICS INC. - Overview
• Exhibits166: THERIVA BIOLOGICS INC. - Product / Service
• Exhibits167: THERIVA BIOLOGICS INC. - Key offerings
• Exhibits168: Inclusions checklist
• Exhibits169: Exclusions checklist
• Exhibits170: Currency conversion rates for US$
• Exhibits171: Research methodology
• Exhibits172: Validation techniques employed for market sizing
• Exhibits173: Information sources
• Exhibits174: List of abbreviations

Abstract

The microbiomes market is forecasted to grow by USD 1,132.78 mn during 2023-2028, accelerating at a CAGR of 22.67% during the forecast period. The report on the microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diseases, increasing initiatives and investments in microbiome research, and advances in microbiome discovery, therapeutics, and diagnostics.

Technavio's microbiomes market is segmented as below:

By Product

• Probiotics
• Foods
• Prebiotics
• Medical food
• Others

By Application

• Therapeutics
• Diagnostics

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the significant number of collaborations for developing microbiome therapeutics as one of the prime reasons driving the microbiomes market growth during the next few years. Also, growing focus on developing biosensors and genetic circuits and developments in regulatory framework will lead to sizable demand in the market.

The report on the microbiomes market covers the following areas:

• Microbiomes market sizing
• Microbiomes market forecast
• Microbiomes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microbiomes market vendors that include AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., YSOPIA Bioscience, and THERIVA BIOLOGICS INC.. Also, the microbiomes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global microbiomes market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global microbiomes market 2018 - 2022 ($ million)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Probiotics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Probiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Probiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Probiotics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Probiotics - Year-over-year growth 2023-2028 (%)
• 6.4 Foods - Market size and forecast 2023-2028
• Exhibit 38: Chart on Foods - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Foods - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Foods - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Foods - Year-over-year growth 2023-2028 (%)
• 6.5 Prebiotics - Market size and forecast 2023-2028
• Exhibit 42: Chart on Prebiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Prebiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Prebiotics - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Prebiotics - Year-over-year growth 2023-2028 (%)
• 6.6 Medical food - Market size and forecast 2023-2028
• Exhibit 46: Chart on Medical food - Market size and forecast 2023-2028 ($ million)
• Exhibit 47: Data Table on Medical food - Market size and forecast 2023-2028 ($ million)
• Exhibit 48: Chart on Medical food - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Medical food - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ million)
• Exhibit 55: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 56: Chart on Application - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 58: Chart on Comparison by Application
• Exhibit 59: Data Table on Comparison by Application
• 7.3 Therapeutics - Market size and forecast 2023-2028
• Exhibit 60: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
• 7.4 Diagnostics - Market size and forecast 2023-2028
• Exhibit 64: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
• Exhibit 66: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Application
• Exhibit 68: Market opportunity by Application ($ million)
• Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 France - Market size and forecast 2023-2028
• Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.10 Japan - Market size and forecast 2023-2028
• Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ million)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 AOBiome LLC
• Exhibit 119: AOBiome LLC - Overview
• Exhibit 120: AOBiome LLC - Product / Service
• Exhibit 121: AOBiome LLC - Key offerings
• 12.4 BiomX Inc.
• Exhibit 122: BiomX Inc. - Overview
• Exhibit 123: BiomX Inc. - Product / Service
• Exhibit 124: BiomX Inc. - Key offerings
• 12.5 DuPont de Nemours Inc.
• Exhibit 125: DuPont de Nemours Inc. - Overview
• Exhibit 126: DuPont de Nemours Inc. - Business segments
• Exhibit 127: DuPont de Nemours Inc. - Key news
• Exhibit 128: DuPont de Nemours Inc. - Key offerings
• Exhibit 129: DuPont de Nemours Inc. - Segment focus
• 12.6 Eligo Bioscience
• Exhibit 130: Eligo Bioscience - Overview
• Exhibit 131: Eligo Bioscience - Product / Service
• Exhibit 132: Eligo Bioscience - Key offerings
• 12.7 ENTEROME SA
• Exhibit 133: ENTEROME SA - Overview
• Exhibit 134: ENTEROME SA - Product / Service
• Exhibit 135: ENTEROME SA - Key offerings
• 12.8 Evelo Biosciences Inc.
• Exhibit 136: Evelo Biosciences Inc. - Overview
• Exhibit 137: Evelo Biosciences Inc. - Product / Service
• Exhibit 138: Evelo Biosciences Inc. - Key offerings
• 12.9 ExeGi Pharma
• Exhibit 139: ExeGi Pharma - Overview
• Exhibit 140: ExeGi Pharma - Product / Service
• Exhibit 141: ExeGi Pharma - Key offerings
• 12.10 Ferring BV
• Exhibit 142: Ferring BV - Overview
• Exhibit 143: Ferring BV - Product / Service
• Exhibit 144: Ferring BV - Key offerings
• 12.11 OraSure Technologies Inc.
• Exhibit 145: OraSure Technologies Inc. - Overview
• Exhibit 146: OraSure Technologies Inc. - Business segments
• Exhibit 147: OraSure Technologies Inc. - Key offerings
• Exhibit 148: OraSure Technologies Inc. - Segment focus
• 12.12 Osel Inc.
• Exhibit 149: Osel Inc. - Overview
• Exhibit 150: Osel Inc. - Product / Service
• Exhibit 151: Osel Inc. - Key offerings
• 12.13 PureTech Health Plc
• Exhibit 152: PureTech Health Plc - Overview
• Exhibit 153: PureTech Health Plc - Business segments
• Exhibit 154: PureTech Health Plc - Key offerings
• Exhibit 155: PureTech Health Plc - Segment focus
• 12.14 Second Genome Therapeutics
• Exhibit 156: Second Genome Therapeutics - Overview
• Exhibit 157: Second Genome Therapeutics - Product / Service
• Exhibit 158: Second Genome Therapeutics - Key offerings
• 12.15 Seres Therapeutics Inc.
• Exhibit 159: Seres Therapeutics Inc. - Overview
• Exhibit 160: Seres Therapeutics Inc. - Product / Service
• Exhibit 161: Seres Therapeutics Inc. - Key offerings
• 12.16 Synlogic Inc.
• Exhibit 162: Synlogic Inc. - Overview
• Exhibit 163: Synlogic Inc. - Product / Service
• Exhibit 164: Synlogic Inc. - Key offerings
• 12.17 THERIVA BIOLOGICS INC.
• Exhibit 165: THERIVA BIOLOGICS INC. - Overview
• Exhibit 166: THERIVA BIOLOGICS INC. - Product / Service
• Exhibit 167: THERIVA BIOLOGICS INC. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 170: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources
• 13.5 List of abbreviations
• Exhibit 174: List of abbreviations